EIF4E threshold levels differ in governing normal and neoplastic expansion of mammary stem and luminal progenitor cells

Cancer Research

Volumn 75, Issue 4, 2015, Pages 687-697

  Avdulov, Svetlana ^a   Herrera, Jeremy ^a   Smith, Karen ^a   Peterson, Mark ^a   Gomez Garcia, Jose R ^a   Beadnell, Thomas C ^b   Schwertfeger, Kathryn L ^b,c   Benyumov, AlexeyO ^a   Manivel, J Carlos ^b,d   Li, Shunan ^a,e,f   Bielinsky, Anja Katrin ^a,c   Yee, Douglas ^a,c   Bitterman, Peter B ^a,c   Polunovsky, Vitaly A ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BioVision Inc   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; HISTONE H2AX; INITIATION FACTOR 4E; MYC PROTEIN; NIBRIN; PROTEIN P53; RAD50 PROTEIN; SINGLE STRANDED DNA; MYC PROTEIN, MOUSE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CARCINOGENESIS; CELL DEATH; CELL EXPANSION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; DNA REPLICATION; FEMALE; GENE OVEREXPRESSION; GESTATION PERIOD; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LACTATION; LUMINAL PROGENITOR CELL; MALIGNANT TRANSFORMATION; MORPHOGENESIS; MOUSE; NONHUMAN; PREGNANCY; PREGNANCY ASSOCIATED BREAST CANCER; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENE; TRANSLATION INITIATION; TUMOR CELL; WEANING; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CANCER STEM CELL; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; PROTEIN SYNTHESIS; UDDER;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL PROLIFERATION; DNA REPLICATION; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; NEOPLASTIC STEM CELLS; PREGNANCY; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-MYC; RAS PROTEINS;

EID: 84923172084     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2571     Document Type: Article

References (45)

1. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009;136:731-45.
2. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Cancer 2010;10:254-66.
3. Bitterman PB, Polunovsky VA. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 2012;11:1097-107.
4. Aitken CE, Lorsch JR. A mechanistic overview of translation initiation in eukaryotes. Nat Struct Mol Biol 2012;19:568-76.
5. Petroulakis E, Parsyan A, Dowling RJ, LeBacquer O,Martineau Y, Bidinosti M, et al. p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell 2009;16:439-46.
6. Kim YY, Von Weymarn L, Larsson O, Fan D, Underwood JM, Peterson MS, et al. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. Cancer Res 2009;69:8455-62.
7. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 50 cap. Nature 1990;345:544-7.
8. Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci U S A 1996;93: 1065-70.
9. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, et al. The translation factor eIF-4E promotes tumor formation and cooperates with cmyc in lymphomagenesis. Nat Med 2004;10:484-6.
10. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, et al. Survival signalling by akt and eIF4E in oncogenesis and cancer therapy. Nature 2004;428:332-7.
11. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006;6:281-91.
12. Fornetti J, Martinson H, Borges V, Schedin P. Emerging targets for the prevention of pregnancy-associated breast cancer. Cell Cycle 2012;11: 639-40.
13. Kumar R, Sukumar S, Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science 1990;248:1101-4.
14. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-15.
15. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006;444:633-7.
16. Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nat Cell Biol 2014;16:2-9.
17. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
18. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, et al. Distinct thresholds govern myc's biological output in vivo. Cancer Cell 2008;14:447-57.
19. Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, et al. Translation factor eIF4E rescues cells from myc-dependent apoptosis by inhibiting cytochrome c release. J Biol Chem 2003;278: 3015-22.
20. Larsson O, Li S, Issaenko OA, Avdulov S, Peterson M, Smith K, et al. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res 2007;67:6814-24.
21. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004;5:553-63.
22. Duncan R, Hershey JW. Regulation of initiation factors during translational repression caused by serum depletion. abundance, synthesis, and turnover rates. J Biol Chem 1985;260:5486-92.
23. Pyronnet S, Sonenberg N. Cell-cycle-dependent translational control. Curr Opin Genet Dev 2001;11:13-8.
24. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunctmammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002;129: 1377-86.
25. Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 2004;23:6980-5.
26. Krepulat F, Lohler J, Heinlein C, Hermannstadter A, Tolstonog GV, Deppert W. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice. Oncogene 2005;24:4645-59.
27. Mack DL, Boulanger CA, Callahan R, Smith GH. Expression of truncated Int6/eIF3e inmammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis. Breast Cancer Res 2007;9:R42.
28. Schulze-Garg C, Lohler J, Gocht A, Deppert W. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of themammary gland. Oncogene 2000;19:1028-37.
29. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell 2007;28:501-12.
30. Rios AC, Fu NY, LindemanGJ, Visvader JE. In situ identification of bipotent stem cells in the mammary gland. Nature 2014;506:322-7.
31. Li Q, Bohin N, Wen T, Ng V, Magee J, Chen SC, et al. Oncogenic nras has bimodal effects on stem cells that sustainably increase competitiveness. Nature 2013;504:143-7.
32. Dontu G, Abdallah WM, Foley JM, Jackson KW, ClarkeMF, KawamuraMJ, et al. In vitro propagation and transcriptional pro filing of humanmammary stem/progenitor cells. Genes Dev 2003;17:1253-70.
33. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010;7:403-17.
34. Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, Povlsen LK, et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 2013;155:1088-103.
35. Curtin NJ. DNA repair dysregulation from cancer driver to therapeutic target. Nat Rev Cancer 2012;12:801-17.
36. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006;444:638-42.
37. Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N, et al. Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated myc. Mol Cell Biol 1996;16:6573-81.
38. Stumpf CR, Moreno MV, Olshen AB, Taylor BS, Ruggero D. The translational landscape of the mammalian cell cycle. Mol Cell 2013;52: 574-82.
39. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;434: 907-13.
40. Stracker TH, Petrini JH. The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol 2011;12:90-103.
41. Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008;319: 1352-5.
42. Cunningham JT, Moreno MV, Lodi A, Ronen SM, Ruggero D. Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cell 2014;157:1088-103.
43. Bitterman PB, Polunovsky VA. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation. Mol Cancer Ther 2012;11:1051-61.
44. Hsieh AC, Truitt ML, Ruggero D. Oncogenic AKTivation of translation as a therapeutic target. Br J Cancer 2011;105:329-36.
45. Nasr Z, Robert F, Porco JA Jr, Muller WJ, Pelletier J. eIF4F suppression in breast cancer affects maintenance and progression. Oncogene 2013;32: 861-71.